Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:1239 (28 May), doi:10.1136/bmj.38441.429618.8F (published 23 May 2005)
Oliver Rivero-Arias, research officer1, Helen Campbell, research officer1, Alastair Gray, professor of health economics1, Jeremy Fairbank, consultant orthopaedic surgeon2, Helen Frost, research fellow3, James Wilson-MacDonald, consultant orthopaedic surgeon2, for the Spine Stabilisation Trial Group
1 Health Economics Research Centre, Department of Public Health, University of Oxford, Oxford OX3 7LF Oliver, 2 Nuffield Orthopaedic Centre, Oxford OX3 7LD, 3 Division of Health in the Community, University of Warwick, Warwick CV4 7AL
Correspondence to: H Campbell helen.campbell{at}dphpc.ox.ac.uk
Objective To determine whether, from a health provider and patient perspective, surgical stabilisation of the spine is cost effective when compared with an intensive programme of rehabilitation in patients with chronic low back pain.
Design Economic evaluation alongside a pragmatic randomised controlled trial.
Setting Secondary care.
Participants 349 patients randomised to surgery (n = 176) or to an intensive rehabilitation programme (n = 173) from 15 centres across the United Kingdom between June 1996 and February 2002.
Main outcome measures Costs related to back pain and incurred by the NHS and patients up to 24 months after randomisation. Return to paid employment and total hours worked. Patient utility as estimated by using the EuroQol EQ-5D questionnaire at several time points and used to calculate quality adjusted life years (QALYs). Cost effectiveness was expressed as an incremental cost per QALY.
Results At two years, 38 patients randomised to rehabilitation had received rehabilitation and surgery whereas just seven surgery patients had received both treatments. The mean total cost per patient was estimated to be £7830 (SD £5202) in the surgery group and £4526 (SD £4155) in the intensive rehabilitation arm, a significant difference of £3304 (95% confidence interval £2317 to £4291). Mean QALYs over the trial period were 1.004 (SD 0.405) in the surgery group and 0.936 (SD 0.431) in the intensive rehabilitation group, giving a non-significant difference of 0.068 (0.020 to 0.156). The incremental cost effectiveness ratio was estimated to be £48 588 per QALY gained (£279 883 to £372 406).
Conclusion Two year follow-up data show that surgical stabilisation of the spine may not be a cost effective use of scarce healthcare resources. However, sensitivity analyses show that this could changefor example, if the proportion of rehabilitation patients requiring subsequent surgery continues to increase.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care